Various commonly used antiseptics were tested against three strains of methicillin-resistant Staphylococcus aureus (MRSA) at stock strength and in serial 10-fold dilutions. The stock solutions of 4% chlorhexidine gluconate-alcohol (Hibiclens), 1% p-chloro-m-xylenol (Acute-Kare), and 3% hexachlorophene (Phisohex) produced 2-log reductions of MRSA after a 15-s exposure, but even after 240 s, these solutions failed to kill all the MRSA. Povidone-iodine (Betadine) solution was maximally effective at the 1:100 dilution, killing all the MRSA within 15 s; other dilutions were less effective, though each killed the MRSA within 120 s. Similar results were obtained with three different strains of methicillin-susceptible S. aureus. Thus, of the four most commonly used antiseptics, povidone-iodine, when diluted 1:100, was the most rapidly bactericidal against both MRSA and methicillin-susceptible S. aureus.
Bathing patients in antiseptic solutions has frequently been done to reduce the carriage of Staphylococcus aureus during staphylococcal epidemics (1, 5, 7) . Usually, hexachlorophene is the antiseptic used in such epidemics. The failure of hexachlorophene to reduce the carriage of methicillin-resistant S. aureus (MRSA) during a recent epidemic at our institution led us to compare the in vitro activities of commonly used antiseptics against this organism.
(This work was presented in part at the annual meeting of the American Society for Microbiology, St. Louis, Mo inactivating solution to the other antiseptic solutions; the colonies were uniformly distributed on the plates subcultured from the hexachlorophene and chloroxylenol solutions, but the colonies were all peripherally located on the plates from the chlorhexidine stock solutions and 1:10 dilution.
A 1-ml volume of the bacterial inoculation was added to 10 ml of each antiseptic solution and vortexed for 10 s. At 15, 30, 60, 120, and 240 s, a 0.5-ml sample of the mixture was removed, immediately added to 4.5 ml of the inactivating solution, and vortexed. A 0.1-ml sample of this suspension was transferred to a blood agar plate and spread with a bent sterile glass rod. The plates were incubated overnight at 37°C, and the resulting colonies were counted.
In experiments involving MRSA, the stock solutions of each of the antiseptics produced a 2-log reduction of CFU within 4 min ( Table 1) . Upon dilution, the povidone-iodine solution retained bactericidal activity even at a 1:10,000 dilution. This solution produced a reduction in CFU greater than 3 log in 15 s at a 1:100 dilution (60 s at a 1:10,000 dilution). The povidone-iodine solution was more rapidly bactericidal in the first three dilutions and less rapidly bactericidal in the last, with the 1:10,000 dilution behaving like the stock solution. The other antiseptics became less rapidly bactericidal at progressively higher dilutions. All four stock solutions were similar in the rapidity of bactericidal action, but all the dilutions of povidone-iodine had a significantly more rapid action than the dilutions of other antiseptics (P = 0.05, sign test).
Experiments with MSSA strains produced results similar to those obtained with MRSA (Table 2) . Povidone-iodine solution was again the most rapidly bactericidal agent studied. Strains of MSSA differed from strains of MRSA only with regard to susceptibility to 3% hexachlorophene and 1% p-chloro-m-xylenol. The killing of MSSA strains was more rapid than the killing of MRSA strains in each of the dilutions of these antiseptics.
Commonly used in vitro methods for testing antiseptic efficacy, such as those recommended by the Food and Drug Administration, incorporate an extended exposure of the microorganisms to the antiseptic, i.e., 8 min by the KelseySykes phenol coefficient procedure and 18 h by the method for determining MICs (3). The procedure used in the present study was originally described by Berkelman et al. (2) and takes into account both the brief exposure time and the dilute solutions encountered when antiseptics are used to bathe patients.
Thus, under conditions most closely approximating those encountered in the clinical situation, povidone-iodine solution proved to be the antiseptic that most rapidly kills S.
aureus. The other antiseptics tested were considerably less effective when diluted than dilute povidone-iodine. Although clinical decisions should not be based on the results of this study alone, povidone-iodine solutions would appear to be the antiseptics of choice for cleansing the skin of MRSA, at least compared with chlorhexidine, chloroxylenol, or hexachlorophene.
Nevertheless, two factors to consider other than the relative bactericidal activities of the antiseptics are the persistence of antiseptics on the skin and their propensity for irritating the skin. Both chlorhexidine and hexachlorophene have persistent antibacterial effects, even at low concentrations; povidone-iodine solutions have no such activity (9) . All of these antiseptics may cause dermatitis if used repeatedly (4, 6) . However, povidone-iodine is particularly problematic in this regard. Thus, the proper role of povidone-iodine solutions in the control of MRSA epidemics is unclear and will have to be defined by carefully controlled clinical trials.
